ADMA ADMA BIOLOGICS, INC.

Nasdaq admabiologics.com


$ 14.37 $ -0.20 (-1.37 %)    

Friday, 17-Oct-2025 15:59:55 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 14.36
$ 14.43
$ 14.27 x 1
$ 15.05 x 100
$ 14.13 - $ 14.60
$ 13.50 - $ 25.67
2,109,554
na
nm
$ 0.53
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 03-18-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-28-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-23-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-10-2022 06-30-2022 10-Q
14 05-11-2022 03-31-2022 10-Q
15 03-24-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
18 05-12-2021 03-31-2021 10-Q
19 03-25-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-05-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 03-13-2020 12-31-2019 10-K
24 11-06-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-08-2019 03-31-2019 10-Q
27 03-13-2019 12-31-2018 10-K
28 11-09-2018 09-30-2018 10-Q
29 08-10-2018 06-30-2018 10-Q
30 05-14-2018 03-31-2018 10-Q
31 03-29-2018 12-31-2017 10-K
32 11-03-2017 09-30-2017 10-Q
33 08-11-2017 06-30-2017 10-Q
34 05-12-2017 03-31-2017 10-Q
35 02-24-2017 12-31-2016 10-K
36 11-10-2016 09-30-2016 10-Q
37 08-12-2016 06-30-2016 10-Q
38 05-13-2016 03-31-2016 10-Q
39 03-23-2016 12-31-2015 10-K
40 11-10-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 adma-biologics-sees-fy2026-sales-500000m-625000m-vs-64117m-est

ADMA Biologics (NASDAQ:ADMA) sees FY2026 sales of $500.000 million-$625.000 million vs $641.17 million analyst estimate.

 adma-biologics-sees-fy2025-sales-500000m-625000m-vs-50767m-est

ADMA Biologics (NASDAQ:ADMA) sees FY2025 sales of $500.000 million-$625.000 million vs $507.67 million analyst estimate.

 adma-biologics-q2-adj-eps-014-inline-sales-12198m-miss-12267m-estimate

ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate. This is a...

 raymond-james-maintains-strong-buy-on-adma-biologics-raises-price-target-to-32

Raymond James analyst Elliot Wilbur maintains ADMA Biologics (NASDAQ:ADMA) with a Strong Buy and raises the price target fro...

 adma-biologics-fy2026--revenue-expected-to-be-more-than-62500m-vs-62923m-est

ADMA Biologics (NASDAQ:ADMA) FY2026 Revenue expected to be more than $625.00M vs $629.23M Est

 adma-biologics-fy2025--revenue-expected-to-be-more-than-50000m-vs-49510m-est

ADMA Biologics (NASDAQ:ADMA) FY2025 Revenue expected to be more than $500.00M vs $495.10M Est

 adma-biologics-q1-adj-eps-014-misses-016-estimate-sales-11480m-miss-11640m-estimate

ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.1...

 adma-biologics-earnings-preview
ADMA Biologics Earnings Preview
05/06/2025 15:01:20

 whats-going-on-with-adma-stock-monday

ADM shares are trading higher Monday after the company announced the FDA's approval of its yield enhancement process.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION